Content area
Abstract
Fetal RhD genotyping from maternal plasma would substantially reduce unnecessary administration of anti-RhD immunoglobulin to RhD-negative women with RhD-negative fetuses.
You might have access to more details...
Try and log in through your library or institution to see if they have access.
Fetal RhD genotyping from maternal plasma would substantially reduce unnecessary administration of anti-RhD immunoglobulin to RhD-negative women with RhD-negative fetuses.